マーケットレポート詳細

臓器チップ(Organ-On-Chip)市場:2029年に至る臓器タイプ別、用途別予測

Organ-On-Chip Market by Organ Type (Liver, Kidney, Intestine, Lung, Heart), Products (Instruments, Consumable, Software), Services (Standard, Custom), Model Type, Application (Toxicology, Drug Discovery, Stem Cell), Purpose - Global Forecast to 2029

出版元:MarketsandMarkets   出版元について
発行年:2024年2月
定価 :Single User License(1名様ライセンス)US$4,950(米国ドル)/ Multi User License(5名様)$6,650 / Corporate User License $8,150
ご予算に応じた各種ご提案も承ります。詳細はお問い合わせください。
ご請求は円換算(お見積り日TTSレート)となります。
納品形態:PDF by Email
当調査レポートは英文338ページになります。
商品コード:MAM3546

お問い合わせ、お見積りのリクエストは下のボタンをクリックしてご入力ください。

【レポート紹介】

臓器チップ(Organ-On-Chip)の世界市場規模は2024年で6億3107万3000ドル、2029年に1億2328万5000ドル、市場の平均年成長率は38.6%にて増加すると見込まれています。

レポートは臓器チップ(Organ-On-Chip)の世界市場について2029年までの市場予測データ(金額US$)を掲載しています。同市場をさまざまな区分で細分化し、そのセグメント市場ごとの市場予測(臓器タイプ別市場、モデルタイプ別市場、等)を中心に構成されています。また競合状況、主要企業情報(14社)、ファイブフォース分析、主要なステークホルダーと購買基準なども加味し、臓器チップ(Organ-On-Chip)市場の動向および今後成長性を詳細にレポートしています。

【レポート構成概要】

◆臓器チップ(Organ-On-Chip)市場の世界市場予測2022-2029年

・市場規模(US$)

◆臓器タイプ別、市場-2029年

・肝臓
・腎臓
・腸
・肺
・心臓
・その他臓器
※(市場規模US$) 

◆モデルタイプ別、市場-2029年

・臓器ベースモデル
・疾患ベースモデル
※(市場規模US$) 

◆製品サービス別、市場-2029年

サービス
・カスタムサービス
・スタンダードサービス
製品
・器具
・消耗品、アクセサリー
・ソフトウェア
※(市場規模US$) 

◆用途別、市場-2029年

・毒物研究
・創薬
・生理学的モデル開発
・組織再生、再生医療
・幹細胞研究
※(市場規模US$) 

◆目的別、市場-2029年

・治療
・研究
※(市場規模US$)

◆エンドユーザー別、市場-2029年

・製薬、バイオテクノロジー企業
・化粧品産業
・学術、研究機関
・その他エンドユーザー
※(市場規模US$)

◆主要国地域別市場-2029年

北米
・米国、カナダ
欧州
・ドイツ、英国、フランス
・イタリア、スペイン
・その他欧州
アジア太平洋
・日本、中国、インド
・オーストラリア、韓国
・その他アジア太平洋
中南米
・ブラジル、メキシコ
その他中南米
・中東アフリカ

※地域、国別に、全セグメント別の細分化データ掲載、詳細は目次参照

◆市場分析

・市場ダイナミクス
・平均価格分析
・バリューチェーン分析
・エコシステム分析
・特許分析
・サプライチェーン分析
・技術分析
・ケーススタディ分析
・貿易分析
・規制状況
・ファイブフォース分析
・主要なステークホルダーと購買基準
・競合状況
・市場シェア分析

◆臓器チップ(Organ-On-Chip)市場の主要企業プロフィール動向

・EMULATE, INC           
・MIMETAS BV
・TISSUSE GMBH          
・CN BIO INNOVATIONS LTD  
・INSPHERO    
・ALVEOLIX AG            
・FLUIGENT    
・NORTIS, INC 
・HESPEROS, INC          
・AXOSIM         
・BEONCHIP    
・ALTIS BIOSYSTEMS   
・SYNVIVO, INC             
・OBATALA SCIENCES 
・DYNAMIC GMBH       
・LENA BIOSCIENCES  
・AIM BIOTECH PTE LTD          
・REACTLIFE   
・INITIO CELL 
・NETRI SAS     
・REVIVOCELL
・BI/OND         
・BIOMIMX SRL
・CHERRY BIOTECH    
・ELVESYS       
・JAVELIN BIOTECH    
・KIRKSTALL LTD        
(全338頁)
【レポート詳細目次、データ項目一覧は当ページ下を参照ください】

Table of Contents (英文詳細目次)

1      INTRODUCTION

1.1             STUDY OBJECTIVES
1.2             MARKET DEFINITION
1.3             INCLUSIONS & EXCLUSIONS
1.4             MARKET SCOPE
・     FIGURE 1            ORGANS-ON-CHIPS MARKET SEGMENTATION
・     FIGURE 2            REGIONAL SEGMENTATION
1.4.1              YEARS CONSIDERED
1.4.2              CURRENCY CONSIDERED
1.5             RESEARCH LIMITATIONS
1.6             STAKEHOLDERS
1.7             SUMMARY OF CHANGES
1.7.1              RECESSION IMPACT

2      RESEARCH METHODOLOGY

2.1             RESEARCH DATA
・     FIGURE 3            RESEARCH DESIGN
2.1.1              SECONDARY DATA
2.1.2              PRIMARY DATA
・     FIGURE 4            BREAKDOWN OF PRIMARIES: SUPPLY- AND DEMAND-SIDE PARTICIPANTS
2.2             MARKET SIZE ESTIMATION
・     FIGURE 5            MARKET SIZE ESTIMATION: SUPPLY-SIDE ANALYSIS, 2023
・     FIGURE 6            MARKET SIZE ESTIMATION: APPROACH 1 (REVENUE SHARE ANALYSIS), 2023
・     FIGURE 7            MARKET VALIDATION FROM PRIMARY EXPERTS
2.2.1              MARKET SIZE ASSESSMENT AT SEGMENTAL LEVEL
・     FIGURE 8            MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
2.3             MARKET GROWTH FORECAST
・     FIGURE 9            CAGR PROJECTIONS: ORGANS-ON-CHIPS MARKET, 2024–2029
・     FIGURE 10          GROWTH ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN ORGANS-ON-CHIPS MARKET  60
2.4             MARKET BREAKDOWN & DATA TRIANGULATION
・     FIGURE 11          DATA TRIANGULATION METHODOLOGY
2.5             STUDY ASSUMPTIONS
2.6             RISK ANALYSIS
2.7             RECESSION IMPACT ANALYSIS
・     TABLE 1              GLOBAL INFLATION RATE PROJECTIONS, 2021–2028 (% GROWTH)
・     TABLE 2              US HEALTH EXPENDITURE, 2019–2022 (USD MILLION)
・     TABLE 3              US HEALTH EXPENDITURE, 2023–2030 (USD MILLION)

3      EXECUTIVE SUMMARY

・     FIGURE 12          ORGANS-ON-CHIPS MARKET, BY ORGAN TYPE,  2024 VS. 2029 (USD THOUSAND)
・     FIGURE 13          ORGANS-ON-CHIPS MARKET, BY MODEL TYPE,  2024 VS. 2029 (USD THOUSAND)
・     FIGURE 14          ORGANS-ON-CHIPS MARKET, BY PRODUCT & SERVICE,  2024 VS. 2029 (USD THOUSAND)
・     FIGURE 15          ORGANS-ON-CHIPS MARKET, BY PURPOSE, 2024 VS. 2029 (USD THOUSAND)
・     FIGURE 16          ORGANS-ON-CHIPS MARKET, BY APPLICATION,  2024 VS. 2029 (USD THOUSAND)
・     FIGURE 17          ORGANS-ON-CHIPS MARKET, BY END USER, 2024 VS. 2029 (USD THOUSAND)
・     FIGURE 18          GEOGRAPHICAL SNAPSHOT: ORGANS-ON-CHIPS MARKET

4      PREMIUM INSIGHTS

4.1             ORGANS-ON-CHIPS MARKET OVERVIEW
・     FIGURE 19          RISING ADOPTION OF ORGANS-ON-CHIPS BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO DRIVE MARKET
4.2             NORTH AMERICA: ORGANS-ON-CHIPS MARKET SHARE,  BY MODEL TYPE & COUNTRY (2023)
・     FIGURE 20          ORGAN-BASED MODELS TO DOMINATE NORTH AMERICAN ORGANS-ON-CHIPS MARKET IN 2023
4.3             ORGANS-ON-CHIPS MARKET, BY APPLICATION,  2024 VS. 2029 (USD THOUSAND)
・     FIGURE 21          TOXICOLOGY RESEARCH TO DOMINATE MARKET BY 2029
4.4             ORGANS-ON-CHIPS MARKET SHARE, BY END USER, 2023
・     FIGURE 22          PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES ACCOUNTED FOR LARGEST MARKET SHARE IN 2023
4.5             ORGANS-ON-CHIPS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
・     FIGURE 23          GERMANY TO REGISTER HIGHEST GROWTH RATE IN ORGANS-ON-CHIPS MARKET FROM 2024 TO 2029

5      MARKET OVERVIEW

5.1             INTRODUCTION
5.2             MARKET DYNAMICS
・     FIGURE 24          ORGANS-ON-CHIPS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
・     TABLE 4              ORGANS-ON-CHIPS MARKET: IMPACT ANALYSIS
5.2.1              DRIVERS
5.2.1.1            INCREASING DEMAND FOR ANIMAL-FREE TESTING
5.2.1.2            ETHICAL CONCERNS REGARDING USE OF ANIMAL MODELS IN DRUG DEVELOPMENT
5.2.1.3            GROWING DRUG DISCOVERY & DEVELOPMENT INITIATIVES
5.2.1.4            DEVELOPMENT OF PERSONALIZED MEDICINES
5.2.1.5            ADVANCEMENTS IN MICROFLUIDICS AND BIOENGINEERING
5.2.1.6            INCREASED GOVERNMENT AND PRIVATE FUNDING
5.2.1.7            GREATER ADOPTION OF OOC TECHNOLOGY BY PHARMA & BIOTECH COMPANIES
5.2.2              RESTRAINTS
5.2.2.1            LIMITATION OF USE RESTRICTED TO PRECLINICAL TRIALS
5.2.2.2            LIMITED SCALABILITY AND THROUGHPUT
5.2.3              OPPORTUNITIES
5.2.3.1            DEVELOPMENT OF HUMAN-ON-A-CHIP MODELS
5.2.3.2            INCREASING APPLICATIONS IN DIVERSE INDUSTRIES
5.2.3.3            DEVELOPING HYBRID BUSINESS MODEL PROVIDING BOTH PRODUCTS AND SERVICES
5.2.4              CHALLENGES
5.2.4.1            LACK OF STANDARDIZATION
5.2.4.2            MIMICKING COMPLEX TISSUES AND ORGANS
5.3             TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
・     FIGURE 25          REVENUE SHIFT & NEW POCKETS FOR PRODUCT & SERVICE PROVIDERS
5.4             PRICING ANALYSIS
・     TABLE 5              AVERAGE SELLING PRICE FOR KEY PLAYERS, BY PRODUCT
5.5             VALUE CHAIN ANALYSIS
・     FIGURE 26          VALUE CHAIN ANALYSIS: RESEARCH & DEVELOPMENT PHASE ADDS MAXIMUM VALUE
5.6             ECOSYSTEM ANALYSIS
・     FIGURE 27          ECOSYSTEM ANALYSIS: ORGANS-ON-CHIPS MARKET
5.7             PATENT ANALYSIS
・     FIGURE 28          PATENT APPLICATIONS FOR ORGAN-ON-A-CHIP PRODUCTS, JANUARY 2012–DECEMBER 2023
・     TABLE 6              ORGANS-ON-CHIPS MARKET: INDICATIVE LIST OF PATENTS
5.8             SUPPLY CHAIN ANALYSIS
・     FIGURE 29          ORGANS-ON-CHIPS MARKET: SUPPLY CHAIN ANALYSIS
・     TABLE 7              OVERALL SUPPLY CHAIN ECOSYSTEM FOR ORGANS-ON-CHIPS MARKET
5.9             TECHNOLOGY ANALYSIS
5.10          CASE STUDY ANALYSIS
5.10.1            QUEEN MARY UNIVERSITY LONDON (QMUL) COLLABORATED WITH EMULATE TO ESTABLISH QUEEN MARY+EMULATE ORGANS-ON-CHIPS CENTRE
5.11          TRADE ANALYSIS
5.12          KEY CONFERENCES & EVENTS IN 2024
・     TABLE 8              ORGANS-ON-CHIPS MARKET: DETAILED LIST OF CONFERENCES & EVENTS
5.13          REGULATORY ANALYSIS
5.13.1            REGULATORY ANALYSIS
5.13.2            REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
・     TABLE 9              NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
・     TABLE 10            EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
・     TABLE 11            ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
・     TABLE 12            REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.14          PORTER’S FIVE FORCES ANALYSIS
・     TABLE 13            ORGANS-ON-CHIPS MARKET: PORTER’S FIVE FORCES ANALYSIS
5.14.1            THREAT OF NEW ENTRANTS
5.14.2            THREAT OF SUBSTITUTES
5.14.3            BARGAINING POWER OF BUYERS   97
5.14.4            BARGAINING POWER OF SUPPLIERS
5.14.5            DEGREE OF COMPETITION
5.15          KEY STAKEHOLDERS & BUYING CRITERIA
5.15.1            KEY STAKEHOLDERS IN BUYING PROCESS
・     FIGURE 30          INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF PRODUCTS
・     FIGURE 31          KEY BUYING CRITERIA FOR END USERS

6      ORGANS-ON-CHIPS MARKET, BY ORGAN TYPE

6.1             INTRODUCTION
・     TABLE 14            ORGANS-ON-CHIPS MARKET, BY ORGAN TYPE, 2022–2029 (USD THOUSAND)
6.2             LIVER
6.2.1              INCREASING PRECLINICAL RESEARCH TO EVALUATE HEPATOTOXICITY TO AID MARKET GROWTH
・     TABLE 15            LIVER-ON-A-CHIP MARKET, BY REGION, 2022–2029 (USD THOUSAND)
・     TABLE 16            NORTH AMERICA: LIVER-ON-A-CHIP MARKET, BY COUNTRY,  2022–2029 (USD THOUSAND)
・     TABLE 17            EUROPE: LIVER-ON-A-CHIP MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND)
・     TABLE 18            ASIA PACIFIC: LIVER-ON-A-CHIP MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND)
・     TABLE 19            LATIN AMERICA: LIVER-ON-A-CHIP MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND)
6.3             KIDNEY
6.3.1              USE OF KIDNEY-ON-A-CHIP MODELS FOR DIKI ASSESSMENT TO SUPPORT MARKET GROWTH
・     TABLE 20            KIDNEY-ON-A-CHIP MARKET, BY REGION, 2022–2029 (USD THOUSAND)
・     TABLE 21            NORTH AMERICA: KIDNEY-ON-A-CHIP MARKET, BY COUNTRY,  2022–2029 (USD THOUSAND)
・     TABLE 22            EUROPE: KIDNEY-ON-A-CHIP MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND)
・     TABLE 23            ASIA PACIFIC: KIDNEY-ON-A-CHIP MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND)
・     TABLE 24            LATIN AMERICA: KIDNEY-ON-A-CHIP MARKET, BY COUNTRY,  2022–2029 (USD THOUSAND)
6.4             INTESTINE   106
6.4.1              INCREASING RESEARCH ON GASTROINTESTINAL DISEASE TO PROMOTE GROWTH
・     TABLE 25            INTESTINE-ON-A-CHIP MARKET, BY REGION, 2022–2029 (USD THOUSAND)
・     TABLE 26            NORTH AMERICA: INTESTINE-ON-A-CHIP MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND)
・     TABLE 27            EUROPE: INTESTINE-ON-A-CHIP MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND)
・     TABLE 28            ASIA PACIFIC: INTESTINE-ON-A-CHIP MARKET, BY COUNTRY,  2022–2029 (USD THOUSAND)
・     TABLE 29            LATIN AMERICA: INTESTINE-ON-A-CHIP MARKET, BY COUNTRY,  2022–2029 (USD THOUSAND)
6.5             LUNG
6.5.1              ENHANCED PARTICLE SCREENING FOR EVALUATING PULMONARY TOXICITY TO SUPPORT ADOPTION
・     TABLE 30            LUNG-ON-A-CHIP MARKET, BY REGION, 2022–2029 (USD THOUSAND)
・     TABLE 31            NORTH AMERICA: LUNG-ON-A-CHIP MARKET, BY COUNTRY,  2022–2029 (USD THOUSAND)
・     TABLE 32            EUROPE: LUNG-ON-A-CHIP MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND)
・     TABLE 33            ASIA PACIFIC: LUNG-ON-A-CHIP MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND)
・     TABLE 34            LATIN AMERICA: LUNG-ON-A-CHIP MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND)
6.6             HEART
6.6.1              INCREASING ADOPTION IN STUDYING CARDIOVASCULAR DISEASES TO DRIVE MARKET
・     TABLE 35            HEART-ON-A-CHIP MARKET, BY REGION, 2022–2029 (USD THOUSAND)
・     TABLE 36            NORTH AMERICA: HEART-ON-A-CHIP MARKET, BY COUNTRY,  2022–2029 (USD THOUSAND)
・     TABLE 37            EUROPE: HEART-ON-A-CHIP MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND)
・     TABLE 38            ASIA PACIFIC: HEART-ON-A-CHIP MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND)
・     TABLE 39            LATIN AMERICA: HEART-ON-A-CHIP MARKET, BY COUNTRY,  2022–2029 (USD THOUSAND)
6.7             OTHER ORGANS
・     TABLE 40            OTHER ORGANS-ON-CHIPS MARKET, BY REGION, 2022–2029 (USD THOUSAND)
・     TABLE 41            NORTH AMERICA: OTHER ORGANS-ON-CHIPS MARKET, BY COUNTRY,  2022–2029 (USD THOUSAND)
・     TABLE 42            EUROPE: OTHER ORGANS-ON-CHIPS MARKET, BY COUNTRY,  2022–2029 (USD THOUSAND)
・     TABLE 43            ASIA PACIFIC: OTHER ORGANS-ON-CHIPS MARKET, BY COUNTRY,  2022–2029 (USD THOUSAND)
・     TABLE 44            LATIN AMERICA: OTHER ORGANS-ON-CHIPS MARKET, BY COUNTRY,  2022–2029 (USD THOUSAND)

7      ORGANS-ON-CHIPS MARKET, BY MODEL TYPE

7.1             INTRODUCTION
・     TABLE 45            ORGANS-ON-CHIPS MARKET, BY MODEL TYPE, 2022–2029 (USD THOUSAND)
7.2             ORGAN-BASED MODELS
7.2.1              INCREASING RESEARCH TO UNDERSTAND ORGAN PHYSIOLOGY TO SUPPORT MARKET GROWTH
・     TABLE 46            ORGANS-ON-CHIPS MARKET FOR ORGAN-BASED MODELS, BY REGION,  2022–2029 (USD THOUSAND)
・     TABLE 47            NORTH AMERICA: ORGANS-ON-CHIPS MARKET FOR ORGAN-BASED MODELS,  BY COUNTRY, 2022–2029 (USD THOUSAND)
・     TABLE 48            EUROPE: ORGANS-ON-CHIPS MARKET FOR ORGAN-BASED MODELS, BY COUNTRY, 2022–2029 (USD THOUSAND)
・     TABLE 49            ASIA PACIFIC: ORGANS-ON-CHIPS MARKET FOR ORGAN-BASED MODELS, BY COUNTRY, 2022–2029 (USD THOUSAND)  121
・     TABLE 50            LATIN AMERICA: ORGANS-ON-CHIPS MARKET FOR ORGAN-BASED MODELS,  BY COUNTRY, 2022–2029 (USD THOUSAND)
7.3             DISEASE-BASED MODELS
7.3.1              GROWING USE OF OOC PLATFORMS FOR DRUG DISCOVERY & DEVELOPMENT TO SUPPORT MARKET GROWTH
・     TABLE 51            ORGANS-ON-CHIPS MARKET FOR DISEASE-BASED MODELS, BY REGION,  2022–2029 (USD THOUSAND)
・     TABLE 52            NORTH AMERICA: ORGANS-ON-CHIPS MARKET FOR DISEASE-BASED MODELS,  BY COUNTRY, 2022–2029 (USD THOUSAND)
・     TABLE 53            EUROPE: ORGANS-ON-CHIPS MARKET FOR DISEASE-BASED MODELS, BY COUNTRY, 2022–2029 (USD THOUSAND)
・     TABLE 54            ASIA PACIFIC: ORGANS-ON-CHIPS MARKET FOR DISEASE-BASED MODELS, BY COUNTRY, 2022–2029 (USD THOUSAND)
・     TABLE 55            LATIN AMERICA: ORGANS-ON-CHIPS MARKET FOR DISEASE-BASED MODELS,  BY COUNTRY, 2022–2029 (USD THOUSAND)

8      ORGANS-ON-CHIPS MARKET, BY PRODUCT & SERVICE

8.1             INTRODUCTION
・     TABLE 56            ORGANS-ON-CHIPS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD THOUSAND)
8.2             SERVICES
・     TABLE 57            ORGAN-ON-A-CHIP SERVICES MARKET, BY REGION, 2022–2029 (USD THOUSAND)
・     TABLE 58            NORTH AMERICA: ORGAN-ON-A-CHIP SERVICES MARKET, BY COUNTRY,  2022–2029 (USD THOUSAND)
・     TABLE 59            EUROPE: ORGAN-ON-A-CHIP SERVICES MARKET, BY COUNTRY,  2022–2029 (USD THOUSAND)
・     TABLE 60            ASIA PACIFIC: ORGAN-ON-A-CHIP SERVICES MARKET, BY COUNTRY,  2022–2029 (USD THOUSAND)
・     TABLE 61            LATIN AMERICA: ORGAN-ON-A-CHIP SERVICES MARKET, BY COUNTRY,  2022–2029 (USD THOUSAND)
・     TABLE 62            ORGAN-ON-A-CHIP SERVICES MARKET, BY TYPE, 2022–2029 (USD THOUSAND)
8.2.1              CUSTOM SERVICES
8.2.1.1            GROWING DEMAND FOR CUSTOMIZED PLATFORMS FOR THERAPEUTICS AND RESEARCH TO AID GROWTH
・     TABLE 63            CUSTOM SERVICES MARKET, BY REGION, 2022–2029 (USD THOUSAND)
・     TABLE 64            NORTH AMERICA: CUSTOM SERVICES MARKET, BY COUNTRY,  2022–2029 (USD THOUSAND)
・     TABLE 65            EUROPE: CUSTOM SERVICES MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND)
・     TABLE 66            ASIA PACIFIC: CUSTOM SERVICES MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND)
・     TABLE 67            LATIN AMERICA: CUSTOM SERVICES MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND)
8.2.2              STANDARD SERVICES
8.2.2.1            INCREASING USE OF PRE-SEEDED PLATFORMS FOR DRUG TOXICITY ASSESSMENTS TO SUPPORT GROWTH
・     TABLE 68            STANDARD SERVICES MARKET, BY REGION, 2022–2029 (USD THOUSAND)
・     TABLE 69            NORTH AMERICA: STANDARD SERVICES MARKET, BY COUNTRY,  2022–2029 (USD THOUSAND)
・     TABLE 70            EUROPE: STANDARD SERVICES MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND)
・     TABLE 71            ASIA PACIFIC: STANDARD SERVICES MARKET, BY COUNTRY,  2022–2029 (USD THOUSAND)
・     TABLE 72            LATIN AMERICA: STANDARD SERVICES MARKET, BY COUNTRY,  2022–2029 (USD THOUSAND)
8.3             PRODUCTS
・     TABLE 73            ORGAN-ON-A-CHIP PRODUCTS MARKET, BY REGION, 2022–2029 (USD THOUSAND)
・     TABLE 74            NORTH AMERICA: ORGAN-ON-A-CHIP PRODUCTS MARKET, BY COUNTRY,  2022–2029 (USD THOUSAND)
・     TABLE 75            EUROPE: ORGAN-ON-A-CHIP PRODUCTS MARKET, BY COUNTRY,  2022–2029 (USD THOUSAND)
・     TABLE 76            ASIA PACIFIC: ORGAN-ON-A-CHIP PRODUCTS MARKET, BY COUNTRY,  2022–2029 (USD THOUSAND)
・     TABLE 77            LATIN AMERICA: ORGAN-ON-A-CHIP PRODUCTS MARKET, BY COUNTRY,  2022–2029 (USD THOUSAND)
・     TABLE 78            ORGAN-ON-A-CHIP PRODUCTS MARKET, BY TYPE, 2022–2029 (USD THOUSAND)
8.3.1              INSTRUMENTS
8.3.1.1            INCREASING ADOPTION OF PLATFORMS FOR DRUG DISCOVERY AND DEVELOPMENT TO SUPPORT MARKET GROWTH
・     TABLE 79            INSTRUMENTS MARKET, BY REGION, 2022–2029 (USD THOUSAND)
・     TABLE 80            NORTH AMERICA: INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND)
・     TABLE 81            EUROPE: INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND)
・     TABLE 82            ASIA PACIFIC: INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND)
・     TABLE 83            LATIN AMERICA: INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND)
8.3.2              CONSUMABLES & ACCESSORIES
8.3.2.1            GROWING EMPHASIS ON USING OOC MODELS FOR RESEARCH TO DRIVE MARKET
・     TABLE 84            CONSUMABLES & ACCESSORIES MARKET, BY REGION, 2022–2029 (USD THOUSAND)
・     TABLE 85            NORTH AMERICA: CONSUMABLES & ACCESSORIES MARKET, BY COUNTRY,  2022–2029 (USD THOUSAND)
・     TABLE 86            EUROPE: CONSUMABLES & ACCESSORIES MARKET, BY COUNTRY,  2022–2029 (USD THOUSAND)
・     TABLE 87            ASIA PACIFIC: CONSUMABLES & ACCESSORIES MARKET, BY COUNTRY,  2022–2029 (USD THOUSAND)
・     TABLE 88            LATIN AMERICA: CONSUMABLES & ACCESSORIES MARKET, BY COUNTRY,  2022–2029 (USD THOUSAND)
8.3.3              SOFTWARE
8.3.3.1            INCREASING INTEGRATION OF AI FOR DATA ANALYTICS AND PREDICTION TO SUPPORT MARKET GROWTH
・     TABLE 89            SOFTWARE MARKET, BY REGION, 2022–2029 (USD THOUSAND)
・     TABLE 90            NORTH AMERICA: SOFTWARE MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND)
・     TABLE 91            EUROPE: SOFTWARE MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND)
・     TABLE 92            ASIA PACIFIC: SOFTWARE MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND)
・     TABLE 93            LATIN AMERICA: SOFTWARE MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND)

9      ORGANS-ON-CHIPS MARKET, BY APPLICATION

9.1             INTRODUCTION
・     TABLE 94            ORGANS-ON-CHIPS MARKET, BY APPLICATION, 2022–2029 (USD THOUSAND)
9.2             TOXICOLOGY RESEARCH
9.2.1              EFFECTIVE OUTCOMES TO SUPPORT GROWTH
・     TABLE 95            ORGANS-ON-CHIPS MARKET FOR TOXICOLOGY RESEARCH, BY REGION,  2022–2029 (USD THOUSAND)
・     TABLE 96            NORTH AMERICA: ORGANS-ON-CHIPS MARKET FOR TOXICOLOGY RESEARCH,  BY COUNTRY, 2022–2029 (USD THOUSAND)
・     TABLE 97            EUROPE: ORGANS-ON-CHIPS MARKET FOR TOXICOLOGY RESEARCH, BY COUNTRY, 2022–2029 (USD THOUSAND)
・     TABLE 98            ASIA PACIFIC: ORGANS-ON-CHIPS MARKET FOR TOXICOLOGY RESEARCH, BY COUNTRY, 2022–2029 (USD THOUSAND)
・     TABLE 99            LATIN AMERICA: ORGANS-ON-CHIPS MARKET FOR TOXICOLOGY RESEARCH, BY COUNTRY, 2022–2029 (USD THOUSAND)
9.3             DRUG DISCOVERY
9.3.1              INCREASING FOCUS OF PHARMA COMPANIES ON ADOPTING OOC TO SUPPORT GROWTH
・     TABLE 100          ORGANS-ON-CHIPS MARKET FOR DRUG DISCOVERY, BY REGION,  2022–2029 (USD THOUSAND)
・     TABLE 101          NORTH AMERICA: ORGANS-ON-CHIPS MARKET FOR DRUG DISCOVERY, BY COUNTRY, 2022–2029 (USD THOUSAND)
・     TABLE 102          EUROPE: ORGANS-ON-CHIPS MARKET FOR DRUG DISCOVERY, BY COUNTRY,  2022–2029 (USD THOUSAND)
・     TABLE 103          ASIA PACIFIC: ORGANS-ON-CHIPS MARKET FOR DRUG DISCOVERY, BY COUNTRY,  2022–2029 (USD THOUSAND)
・     TABLE 104          LATIN AMERICA: ORGANS-ON-CHIPS MARKET FOR DRUG DISCOVERY, BY COUNTRY, 2022–2029 (USD THOUSAND)
9.4             PHYSIOLOGICAL MODEL DEVELOPMENT
9.4.1              ACCURACY IN STUDYING IN VIVO MECHANISMS TO DRIVE MARKET
・     TABLE 105          ORGANS-ON-CHIPS MARKET FOR PHYSIOLOGICAL MODEL DEVELOPMENT, BY REGION, 2022–2029 (USD THOUSAND)
・     TABLE 106          NORTH AMERICA: ORGANS-ON-CHIPS MARKET FOR PHYSIOLOGICAL MODEL DEVELOPMENT, BY COUNTRY, 2022–2029 (USD THOUSAND)
・     TABLE 107          EUROPE: ORGANS-ON-CHIPS MARKET FOR PHYSIOLOGICAL MODEL DEVELOPMENT,  BY COUNTRY, 2022–2029 (USD THOUSAND)
・     TABLE 108          ASIA PACIFIC: ORGANS-ON-CHIPS MARKET FOR PHYSIOLOGICAL MODEL DEVELOPMENT, BY COUNTRY, 2022–2029 (USD THOUSAND)
・     TABLE 109          LATIN AMERICA: ORGANS-ON-CHIPS MARKET FOR PHYSIOLOGICAL MODEL DEVELOPMENT, BY COUNTRY, 2022–2029 (USD THOUSAND)
9.5             TISSUE REGENERATION & REGENERATIVE MEDICINE
9.5.1              GROWING RESEARCH INITIATIVES TO SUPPORT MARKET GROWTH
・     TABLE 110          ORGANS-ON-CHIPS MARKET FOR TISSUE REGENERATION & REGENERATIVE MEDICINE, BY REGION, 2022–2029 (USD THOUSAND)
・     TABLE 111          NORTH AMERICA: ORGANS-ON-CHIPS MARKET FOR TISSUE REGENERATION & REGENERATIVE MEDICINE, BY COUNTRY, 2022–2029 (USD THOUSAND)
・     TABLE 112          EUROPE: ORGANS-ON-CHIPS MARKET FOR TISSUE REGENERATION & REGENERATIVE MEDICINE, BY COUNTRY, 2022–2029 (USD THOUSAND)
・     TABLE 113          ASIA PACIFIC: ORGANS-ON-CHIPS MARKET FOR TISSUE REGENERATION & REGENERATIVE MEDICINE, BY COUNTRY, 2022–2029 (USD THOUSAND)
・     TABLE 114          LATIN AMERICA: ORGANS-ON-CHIPS MARKET FOR TISSUE REGENERATION & REGENERATIVE MEDICINE, BY COUNTRY, 2022–2029 (USD THOUSAND)
9.6             STEM CELL RESEARCH
9.6.1              GROWING FOCUS ON STEM CELL RESEARCH TO SUPPORT GROWTH
・     TABLE 115          ORGANS-ON-CHIPS MARKET FOR STEM CELL RESEARCH, BY REGION,  2022–2029 (USD THOUSAND)
・     TABLE 116          NORTH AMERICA: ORGANS-ON-CHIPS MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2022–2029 (USD THOUSAND)
・     TABLE 117          EUROPE: ORGANS-ON-CHIPS MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2022–2029 (USD THOUSAND)
・     TABLE 118          ASIA PACIFIC: ORGANS-ON-CHIPS MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2022–2029 (USD THOUSAND)
・     TABLE 119          LATIN AMERICA: ORGANS-ON-CHIPS MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2022–2029 (USD THOUSAND)

10   ORGANS-ON-CHIPS MARKET, BY PURPOSE

10.1          INTRODUCTION
・     TABLE 120          ORGANS-ON-CHIPS MARKET, BY PURPOSE, 2022–2029 (USD THOUSAND)
10.2          THERAPEUTICS
10.2.1            INCREASING USE OF OOC TECHNOLOGY IN PRECISION MEDICINE AND TARGETED THERAPY RESEARCH TO AID GROWTH
・     TABLE 121          ORGANS-ON-CHIPS MARKET FOR THERAPEUTICS, BY REGION,  2022–2029 (USD THOUSAND)
・     TABLE 122          NORTH AMERICA: ORGANS-ON-CHIPS MARKET FOR THERAPEUTICS, BY COUNTRY,  2022–2029 (USD THOUSAND)
・     TABLE 123          EUROPE: ORGANS-ON-CHIPS MARKET FOR THERAPEUTICS, BY COUNTRY,  2022–2029 (USD THOUSAND)
・     TABLE 124          ASIA PACIFIC: ORGANS-ON-CHIPS MARKET FOR THERAPEUTICS, BY COUNTRY,  2022–2029 (USD THOUSAND)
・     TABLE 125          LATIN AMERICA: ORGANS-ON-CHIPS MARKET FOR THERAPEUTICS, BY COUNTRY,  2022–2029 (USD THOUSAND)
10.3          RESEARCH
10.3.1            INCREASING USE OF OOC PLATFORM FOR RESEARCH TO SUPPORT MARKET GROWTH
・     TABLE 126          ORGANS-ON-CHIPS MARKET FOR RESEARCH, BY REGION, 2022–2029 (USD THOUSAND)
・     TABLE 127          NORTH AMERICA: ORGANS-ON-CHIPS MARKET FOR RESEARCH, BY COUNTRY,  2022–2029 (USD THOUSAND)
・     TABLE 128          EUROPE: ORGANS-ON-CHIPS MARKET FOR RESEARCH, BY COUNTRY,  2022–2029 (USD THOUSAND)
・     TABLE 129          ASIA PACIFIC: ORGANS-ON-CHIPS MARKET FOR RESEARCH, BY COUNTRY,  2022–2029 (USD THOUSAND)
・     TABLE 130          LATIN AMERICA: ORGANS-ON-CHIPS MARKET FOR RESEARCH, BY COUNTRY,  2022–2029 (USD THOUSAND)

11   ORGANS-ON-CHIPS MARKET, BY END USER

11.1          INTRODUCTION
・     TABLE 131          ORGANS-ON-CHIPS MARKET, BY END USER, 2022–2029 (USD THOUSAND)
11.2          PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
11.2.1            INCREASING COLLABORATION BETWEEN PHARMACEUTICAL COMPANIES AND OOC MANUFACTURERS TO DRIVE MARKET
・     TABLE 132          ORGANS-ON-CHIPS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022–2029 (USD THOUSAND)
・     TABLE 133          NORTH AMERICA: ORGANS-ON-CHIPS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD THOUSAND)
・     TABLE 134          EUROPE: ORGANS-ON-CHIPS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD THOUSAND)
・     TABLE 135          ASIA PACIFIC: ORGANS-ON-CHIPS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD THOUSAND)
・     TABLE 136          LATIN AMERICA: ORGANS-ON-CHIPS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD THOUSAND)
11.3          COSMETICS INDUSTRY
11.3.1            GROWING EMPHASIS ON ANIMAL-FREE DRUG TESTING TO PROMOTE MARKET GROWTH
・     TABLE 137          ORGANS-ON-CHIPS MARKET FOR COSMETICS INDUSTRY, BY REGION, 2022–2029 (USD THOUSAND)
・     TABLE 138          NORTH AMERICA: ORGANS-ON-CHIPS MARKET FOR COSMETICS INDUSTRY, BY COUNTRY, 2022–2029 (USD THOUSAND)
・     TABLE 139          EUROPE: ORGANS-ON-CHIPS MARKET FOR COSMETICS INDUSTRY,  2022–2029 (USD THOUSAND)
・     TABLE 140          ASIA PACIFIC: ORGANS-ON-CHIPS MARKET FOR COSMETICS INDUSTRY, BY COUNTRY, 2022–2029 (USD THOUSAND)
・     TABLE 141          LATIN AMERICA: ORGANS-ON-CHIPS MARKET FOR COSMETICS INDUSTRY, BY COUNTRY, 2022–2029 (USD THOUSAND)
11.4          ACADEMIC & RESEARCH INSTITUTES
11.4.1            INCREASING RESEARCH INTO APPLICATIONS OF OOC TECHNOLOGY TO SUPPORT MARKET GROWTH
・     TABLE 142          ORGANS-ON-CHIPS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022–2029 (USD THOUSAND)
・     TABLE 143          NORTH AMERICA: ORGANS-ON-CHIPS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD THOUSAND)
・     TABLE 144          EUROPE: ORGANS-ON-CHIPS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD THOUSAND)
・     TABLE 145          ASIA PACIFIC: ORGANS-ON-CHIPS MARKET FOR ACADEMIC & RESEARCH INSTITUTES,  BY COUNTRY, 2022–2029 (USD THOUSAND)
・     TABLE 146          LATIN AMERICA: ORGANS-ON-CHIPS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD THOUSAND)
11.5          OTHER END USERS
・     TABLE 147          ORGANS-ON-CHIPS MARKET FOR OTHER END USERS, BY REGION,  2022–2029 (USD THOUSAND)
・     TABLE 148          NORTH AMERICA: ORGANS-ON-CHIPS MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD THOUSAND)
・     TABLE 149          EUROPE: ORGANS-ON-CHIPS MARKET FOR OTHER END USERS,  2022–2029 (USD THOUSAND)
・     TABLE 150          ASIA PACIFIC: ORGANS-ON-CHIPS MARKET FOR OTHER END USERS, BY COUNTRY,  2022–2029 (USD THOUSAND)
・     TABLE 151          LATIN AMERICA: ORGANS-ON-CHIPS MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD THOUSAND)

12   ORGANS-ON-CHIPS MARKET, BY REGION 

12.1          INTRODUCTION
・     TABLE 152          ORGANS-ON-CHIPS MARKET, BY REGION, 2022–2029 (USD THOUSAND)
12.2          NORTH AMERICA
・     FIGURE 32          NORTH AMERICA: ORGANS-ON-CHIPS MARKET SNAPSHOT
・     TABLE 153          NORTH AMERICA: ORGANS-ON-CHIPS MARKET, BY COUNTRY,  2022–2029 (USD THOUSAND)
・     TABLE 154          NORTH AMERICA: ORGANS-ON-CHIPS MARKET, BY ORGAN TYPE,  2022–2029 (USD THOUSAND)
・     TABLE 155          NORTH AMERICA: ORGANS-ON-CHIPS MARKET, BY MODEL TYPE,  2022–2029 (USD THOUSAND)
・     TABLE 156          NORTH AMERICA: ORGANS-ON-CHIPS MARKET, BY PRODUCT & SERVICE,  2022–2029 (USD THOUSAND)
・     TABLE 157          NORTH AMERICA: ORGAN-ON-A-CHIP PRODUCTS MARKET, BY TYPE,  2022–2029 (USD THOUSAND)
・     TABLE 158          NORTH AMERICA: ORGAN-ON-A-CHIP SERVICES MARKET, BY TYPE,  2022–2029 (USD THOUSAND)
・     TABLE 159          NORTH AMERICA: ORGANS-ON-CHIPS MARKET, BY APPLICATION,  2022–2029 (USD THOUSAND)
・     TABLE 160          NORTH AMERICA: ORGANS-ON-CHIPS MARKET, BY PURPOSE,  2022–2029 (USD THOUSAND)
・     TABLE 161          NORTH AMERICA: ORGANS-ON-CHIPS MARKET, BY END USER,  2022–2029 (USD THOUSAND)
12.2.1            US
12.2.1.1          US TO DOMINATE MARKET DUE TO PRESENCE OF MAJOR COMPANIES
・     TABLE 162          US: ORGANS-ON-CHIPS MARKET, BY ORGAN TYPE, 2022–2029 (USD THOUSAND)
・     TABLE 163          US: ORGANS-ON-CHIPS MARKET, BY MODEL TYPE, 2022–2029 (USD THOUSAND)
・     TABLE 164          US: ORGANS-ON-CHIPS MARKET, BY PRODUCT & SERVICE,  2022–2029 (USD THOUSAND)
・     TABLE 165          US: ORGAN-ON-A-CHIP PRODUCTS MARKET, BY TYPE, 2022–2029 (USD THOUSAND)
・     TABLE 166          US: ORGAN-ON-A-CHIP SERVICES MARKET, BY TYPE, 2022–2029 (USD THOUSAND)
・     TABLE 167          US: ORGANS-ON-CHIPS MARKET, BY APPLICATION, 2022–2029 (USD THOUSAND)
・     TABLE 168          US: ORGANS-ON-CHIPS MARKET, BY PURPOSE, 2022–2029 (USD THOUSAND)
・     TABLE 169          US: ORGANS-ON-CHIPS MARKET, BY END USER, 2022–2029 (USD THOUSAND)
12.2.2            CANADA
12.2.2.1          FAVORABLE REGULATORY ENVIRONMENT TO SUPPORT MARKET GROWTH
・     TABLE 170          CANADA: ORGANS-ON-CHIPS MARKET, BY ORGAN TYPE, 2022–2029 (USD THOUSAND)
・     TABLE 171          CANADA: ORGANS-ON-CHIPS MARKET, BY MODEL TYPE, 2022–2029 (USD THOUSAND)
・     TABLE 172          CANADA: ORGANS-ON-CHIPS MARKET, BY PRODUCT & SERVICE,  2022–2029 (USD THOUSAND)
・     TABLE 173          CANADA: ORGAN-ON-A-CHIP PRODUCTS MARKET, BY TYPE,  2022–2029 (USD THOUSAND)
・     TABLE 174          CANADA: ORGAN-ON-A-CHIP SERVICES MARKET, BY TYPE, 2022–2029 (USD THOUSAND)
・     TABLE 175          CANADA: ORGANS-ON-CHIPS MARKET, BY APPLICATION, 2022–2029 (USD THOUSAND)
・     TABLE 176          CANADA: ORGANS-ON-CHIPS MARKET, BY PURPOSE, 2022–2029 (USD THOUSAND)
・     TABLE 177          CANADA: ORGANS-ON-CHIPS MARKET, BY END USER, 2022–2029 (USD THOUSAND)
12.2.3            NORTH AMERICA: RECESSION IMPACT
12.3          EUROPE
・     FIGURE 33          EUROPE: ORGANS-ON-CHIPS MARKET SNAPSHOT
・     TABLE 178          EUROPE: ORGANS-ON-CHIPS MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND)
・     TABLE 179          EUROPE: ORGANS-ON-CHIPS MARKET, BY ORGAN TYPE, 2022–2029 (USD THOUSAND)
・     TABLE 180          EUROPE: ORGANS-ON-CHIPS MARKET, BY MODEL TYPE, 2022–2029 (USD THOUSAND)
・     TABLE 181          EUROPE: ORGANS-ON-CHIPS MARKET, BY PRODUCT & SERVICE,  2022–2029 (USD THOUSAND)
・     TABLE 182          EUROPE: ORGAN-ON-A-CHIP PRODUCTS MARKET, BY TYPE,  2022–2029 (USD THOUSAND)
・     TABLE 183          EUROPE: ORGAN-ON-A-CHIP SERVICES MARKET, BY TYPE, 2022–2029 (USD THOUSAND)
・     TABLE 184          EUROPE: ORGANS-ON-CHIPS MARKET, BY APPLICATION, 2022–2029 (USD THOUSAND)
・     TABLE 185          EUROPE: ORGANS-ON-CHIPS MARKET, BY PURPOSE, 2022–2029 (USD THOUSAND)
・     TABLE 186          EUROPE: ORGANS-ON-CHIPS MARKET, BY END USER, 2022–2029 (USD THOUSAND)
12.3.1            GERMANY
12.3.1.1          FAVORABLE GOVERNMENT POLICIES TO PROPEL MARKET
・     TABLE 187          GERMANY: ORGANS-ON-CHIPS MARKET, BY ORGAN TYPE, 2022–2029 (USD THOUSAND)
・     TABLE 188          GERMANY: ORGANS-ON-CHIPS MARKET, BY MODEL TYPE, 2022–2029 (USD THOUSAND)
・     TABLE 189          GERMANY: ORGANS-ON-CHIPS MARKET, BY PRODUCT & SERVICE,  2022–2029 (USD THOUSAND)
・     TABLE 190          GERMANY: ORGAN-ON-A-CHIP PRODUCTS MARKET, BY TYPE,  2022–2029 (USD THOUSAND)
・     TABLE 191          GERMANY: ORGAN-ON-A-CHIP SERVICES MARKET, BY TYPE,  2022–2029 (USD THOUSAND)
・     TABLE 192          GERMANY: ORGANS-ON-CHIPS MARKET, BY APPLICATION, 2022–2029 (USD THOUSAND)
・     TABLE 193          GERMANY: ORGANS-ON-CHIPS MARKET, BY PURPOSE, 2022–2029 (USD THOUSAND)
・     TABLE 194          GERMANY: ORGANS-ON-CHIPS MARKET, BY END USER, 2022–2029 (USD THOUSAND)
12.3.2            UK
12.3.2.1          GROWING R&D EXPENDITURE IN PHARMACEUTICAL INDUSTRY TO BOOST MARKET
・     TABLE 195          UK: ORGANS-ON-CHIPS MARKET, BY ORGAN TYPE, 2022–2029 (USD THOUSAND)
・     TABLE 196          UK: ORGANS-ON-CHIPS MARKET, BY MODEL TYPE, 2022–2029 (USD THOUSAND)
・     TABLE 197          UK: ORGANS-ON-CHIPS MARKET, BY PRODUCT & SERVICE,  2022–2029 (USD THOUSAND)
・     TABLE 198          UK: ORGAN-ON-A-CHIP PRODUCTS MARKET, BY TYPE, 2022–2029 (USD THOUSAND)
・     TABLE 199          UK: ORGAN-ON-A-CHIP SERVICES MARKET, BY TYPE, 2022–2029 (USD THOUSAND)
・     TABLE 200          UK: ORGANS-ON-CHIPS MARKET, BY APPLICATION, 2022–2029 (USD THOUSAND)
・     TABLE 201          UK: ORGANS-ON-CHIPS MARKET, BY PURPOSE, 2022–2029 (USD THOUSAND)
・     TABLE 202          UK: ORGANS-ON-CHIPS MARKET, BY END USER, 2022–2029 (USD THOUSAND)
12.3.3            FRANCE
12.3.3.1          GROWING FUNDING FOR RESEARCH PROJECTS TO DRIVE MARKET
・     TABLE 203          FRANCE: ORGANS-ON-CHIPS MARKET, BY ORGAN TYPE, 2022–2029 (USD THOUSAND)
・     TABLE 204          FRANCE: ORGANS-ON-CHIPS MARKET, BY MODEL TYPE, 2022–2029 (USD THOUSAND)
・     TABLE 205          FRANCE: ORGANS-ON-CHIPS MARKET, BY PRODUCT & SERVICE,  2022–2029 (USD THOUSAND)
・     TABLE 206          FRANCE: ORGAN-ON-A-CHIP PRODUCTS MARKET, BY TYPE,  2022–2029 (USD THOUSAND)
・     TABLE 207          FRANCE: ORGAN-ON-A-CHIP SERVICES MARKET, BY TYPE, 2022–2029 (USD THOUSAND)
・     TABLE 208          FRANCE: ORGANS-ON-CHIPS MARKET, BY APPLICATION, 2022–2029 (USD THOUSAND)
・     TABLE 209          FRANCE: ORGANS-ON-CHIPS MARKET, BY PURPOSE, 2022–2029 (USD THOUSAND)
・     TABLE 210          FRANCE: ORGANS-ON-CHIPS MARKET, BY END USER, 2022–2029 (USD THOUSAND)
12.3.4            ITALY
12.3.4.1          GROWING RESEARCH TO AID GROWTH
・     TABLE 211          ITALY: ORGANS-ON-CHIPS MARKET, BY ORGAN TYPE, 2022–2029 (USD THOUSAND)
・     TABLE 212          ITALY: ORGANS-ON-CHIPS MARKET, BY MODEL TYPE, 2022–2029 (USD THOUSAND)
・     TABLE 213          ITALY: ORGANS-ON-CHIPS MARKET, BY PRODUCT & SERVICE,  2022–2029 (USD THOUSAND)
・     TABLE 214          ITALY: ORGAN-ON-A-CHIP PRODUCTS MARKET, BY TYPE, 2022–2029 (USD THOUSAND)
・     TABLE 215          ITALY: ORGAN-ON-A-CHIP SERVICES MARKET, BY TYPE, 2022–2029 (USD THOUSAND)
・     TABLE 216          ITALY: ORGANS-ON-CHIPS MARKET, BY APPLICATION, 2022–2029 (USD THOUSAND)
・     TABLE 217          ITALY: ORGANS-ON-CHIPS MARKET, BY PURPOSE, 2022–2029 (USD THOUSAND)
・     TABLE 218          ITALY: ORGANS-ON-CHIPS MARKET, BY END USER, 2022–2029 (USD THOUSAND)
12.3.5            SPAIN
12.3.5.1          GROWING R&D EXPENDITURE TO BOOST MARKET
・     TABLE 219          SPAIN: ORGANS-ON-CHIPS MARKET, BY ORGAN TYPE, 2022–2029 (USD THOUSAND)
・     TABLE 220          SPAIN: ORGANS-ON-CHIPS MARKET, BY MODEL TYPE, 2022–2029 (USD THOUSAND)
・     TABLE 221          SPAIN: ORGANS-ON-CHIPS MARKET, BY PRODUCT & SERVICE,  2022–2029 (USD THOUSAND)
・     TABLE 222          SPAIN: ORGAN-ON-A-CHIP PRODUCTS MARKET, BY TYPE, 2022–2029 (USD THOUSAND)
・     TABLE 223          SPAIN: ORGAN-ON-A-CHIP SERVICES MARKET, BY TYPE, 2022–2029 (USD THOUSAND)
・     TABLE 224          SPAIN: ORGANS-ON-CHIPS MARKET, BY APPLICATION, 2022–2029 (USD THOUSAND)
・     TABLE 225          SPAIN: ORGANS-ON-CHIPS MARKET, BY PURPOSE, 2022–2029 (USD THOUSAND)
・     TABLE 226          SPAIN: ORGANS-ON-CHIPS MARKET, BY END USER, 2022–2029 (USD THOUSAND)
12.3.6            REST OF EUROPE
・     TABLE 227          REST OF EUROPE: ORGANS-ON-CHIPS MARKET, BY ORGAN TYPE,  2022–2029 (USD THOUSAND)
・     TABLE 228          REST OF EUROPE: ORGANS-ON-CHIPS MARKET, BY MODEL TYPE,  2022–2029 (USD THOUSAND)
・     TABLE 229          REST OF EUROPE: ORGANS-ON-CHIPS MARKET, BY PRODUCT & SERVICE,  2022–2029 (USD THOUSAND)
・     TABLE 230          REST OF EUROPE: ORGAN-ON-A-CHIP PRODUCTS MARKET, BY TYPE,  2022–2029 (USD THOUSAND)
・     TABLE 231          REST OF EUROPE: ORGAN-ON-A-CHIP SERVICES MARKET, BY TYPE,  2022–2029 (USD THOUSAND)
・     TABLE 232          REST OF EUROPE: ORGANS-ON-CHIPS MARKET, BY APPLICATION,  2022–2029 (USD THOUSAND)
・     TABLE 233          REST OF EUROPE: ORGANS-ON-CHIPS MARKET, BY PURPOSE,  2022–2029 (USD THOUSAND)
・     TABLE 234          REST OF EUROPE: ORGANS-ON-CHIPS MARKET, BY END USER,  2022–2029 (USD THOUSAND)
12.3.7            EUROPE: RECESSION IMPACT
12.4          ASIA PACIFIC
・     TABLE 235          ASIA PACIFIC: ORGANS-ON-CHIPS MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND)
・     TABLE 236          ASIA PACIFIC: ORGANS-ON-CHIPS MARKET, BY ORGAN TYPE,  2022–2029 (USD THOUSAND)
・     TABLE 237          ASIA PACIFIC: ORGANS-ON-CHIPS MARKET, BY MODEL TYPE,  2022–2029 (USD THOUSAND)
・     TABLE 238          ASIA PACIFIC: ORGANS-ON-CHIPS MARKET, BY PRODUCT & SERVICE,  2022–2029 (USD THOUSAND)
・     TABLE 239          ASIA PACIFIC: ORGAN-ON-A-CHIP PRODUCTS MARKET, BY TYPE, 2022–2029 (USD THOUSAND)
・     TABLE 240          ASIA PACIFIC: ORGAN-ON-A-CHIP SERVICES MARKET, BY TYPE,  2022–2029 (USD THOUSAND)
・     TABLE 241          ASIA PACIFIC: ORGANS-ON-CHIPS MARKET, BY APPLICATION,  2022–2029 (USD THOUSAND)

・     TABLE 242          ASIA PACIFIC: ORGANS-ON-CHIPS MARKET, BY PURPOSE, 2022–2029 (USD THOUSAND)
・     TABLE 243          ASIA PACIFIC: ORGANS-ON-CHIPS MARKET, BY END USER,  2022–2029 (USD THOUSAND)
12.4.1            CHINA
12.4.1.1          INCREASING INVESTMENTS IN SCIENTIFIC RESEARCH AND TECHNOLOGY TO DRIVE MARKET
・     TABLE 244          CHINA: ORGANS-ON-CHIPS MARKET, BY ORGAN TYPE, 2022–2029 (USD THOUSAND)
・     TABLE 245          CHINA: ORGANS-ON-CHIPS MARKET, BY MODEL TYPE, 2022–2029 (USD THOUSAND)
・     TABLE 246          CHINA: ORGANS-ON-CHIPS MARKET, BY PRODUCT & SERVICE,  2022–2029 (USD THOUSAND)
・     TABLE 247          CHINA: ORGAN-ON-A-CHIP PRODUCTS MARKET, BY TYPE, 2022–2029 (USD THOUSAND)
・     TABLE 248          CHINA: ORGAN-ON-A-CHIP SERVICES MARKET, BY TYPE, 2022–2029 (USD THOUSAND)
・     TABLE 249          CHINA: ORGANS-ON-CHIPS MARKET, BY APPLICATION, 2022–2029 (USD THOUSAND)
・     TABLE 250          CHINA: ORGANS-ON-CHIPS MARKET, BY PURPOSE, 2022–2029 (USD THOUSAND)
・     TABLE 251          CHINA: ORGANS-ON-CHIPS MARKET, BY END USER, 2022–2029 (USD THOUSAND)
12.4.2            JAPAN
12.4.2.1          GROWING INNOVATION IN DRUG RESEARCH TO PROPEL MARKET
・     TABLE 252          JAPAN: ORGANS-ON-CHIPS MARKET, BY ORGAN TYPE, 2022–2029 (USD THOUSAND)
・     TABLE 253          JAPAN: ORGANS-ON-CHIPS MARKET, BY MODEL TYPE, 2022–2029 (USD THOUSAND)
・     TABLE 254          JAPAN: ORGANS-ON-CHIPS MARKET, BY PRODUCT & SERVICE,  2022–2029 (USD THOUSAND)
・     TABLE 255          JAPAN: ORGAN-ON-A-CHIP PRODUCTS MARKET, BY TYPE, 2022–2029 (USD THOUSAND)
・     TABLE 256          JAPAN: ORGAN-ON-A-CHIP SERVICES MARKET, BY TYPE, 2022–2029 (USD THOUSAND)
・     TABLE 257          JAPAN: ORGANS-ON-CHIPS MARKET, BY APPLICATION, 2022–2029 (USD THOUSAND)
・     TABLE 258          JAPAN: ORGANS-ON-CHIPS MARKET, BY PURPOSE, 2022–2029 (USD THOUSAND)
・     TABLE 259          JAPAN: ORGANS-ON-CHIPS MARKET, BY END USER, 2022–2029 (USD THOUSAND)
12.4.3            INDIA
12.4.3.1          RISING RESEARCH TO CREATE FAVORABLE OPPORTUNITIES FOR MARKET PLAYERS
・     TABLE 260          INDIA: ORGANS-ON-CHIPS MARKET, BY ORGAN TYPE, 2022–2029 (USD THOUSAND)
・     TABLE 261          INDIA: ORGANS-ON-CHIPS MARKET, BY MODEL TYPE, 2022–2029 (USD THOUSAND)
・     TABLE 262          INDIA: ORGANS-ON-CHIPS MARKET, BY PRODUCT & SERVICE,  2022–2029 (USD THOUSAND)
・     TABLE 263          INDIA: ORGAN-ON-A-CHIP PRODUCTS MARKET, BY TYPE, 2022–2029 (USD THOUSAND)
・     TABLE 264          INDIA: ORGAN-ON-A-CHIP SERVICES MARKET, BY TYPE, 2022–2029 (USD THOUSAND)
・     TABLE 265          INDIA: ORGANS-ON-CHIPS MARKET, BY APPLICATION, 2022–2029 (USD THOUSAND)
・     TABLE 266          INDIA: ORGANS-ON-CHIPS MARKET, BY PURPOSE, 2022–2029 (USD THOUSAND)
・     TABLE 267          INDIA: ORGANS-ON-CHIPS MARKET, BY END USER, 2022–2029 (USD THOUSAND)
12.4.4            AUSTRALIA
12.4.4.1          INCREASING DRUG DEVELOPMENT INITIATIVES TO SUPPORT MARKET GROWTH
・     TABLE 268          AUSTRALIA: ORGANS-ON-CHIPS MARKET, BY ORGAN TYPE,  2022–2029 (USD THOUSAND)
・     TABLE 269          AUSTRALIA: ORGANS-ON-CHIPS MARKET, BY MODEL TYPE,  2022–2029 (USD THOUSAND)
・     TABLE 270          AUSTRALIA: ORGANS-ON-CHIPS MARKET, BY PRODUCT & SERVICE,  2022–2029 (USD THOUSAND)
・     TABLE 271          AUSTRALIA: ORGAN-ON-A-CHIP PRODUCTS MARKET, BY TYPE,  2022–2029 (USD THOUSAND)
・     TABLE 272          AUSTRALIA: ORGAN-ON-A-CHIP SERVICES MARKET, BY TYPE,  2022–2029 (USD THOUSAND)
・     TABLE 273          AUSTRALIA: ORGANS-ON-CHIPS MARKET, BY APPLICATION,  2022–2029 (USD THOUSAND)
・     TABLE 274          AUSTRALIA: ORGANS-ON-CHIPS MARKET, BY PURPOSE, 2022–2029 (USD THOUSAND)
・     TABLE 275          AUSTRALIA: ORGANS-ON-CHIPS MARKET, BY END USER, 2022–2029 (USD THOUSAND)
12.4.5            SOUTH KOREA
12.4.5.1          GROWING PHARMA SECTOR TO DRIVE MARKET
・     TABLE 276          SOUTH KOREA: ORGANS-ON-CHIPS MARKET, BY ORGAN TYPE,  2022–2029 (USD THOUSAND)
・     TABLE 277          SOUTH KOREA: ORGANS-ON-CHIPS MARKET, BY MODEL TYPE,  2022–2029 (USD THOUSAND)
・     TABLE 278          SOUTH KOREA: ORGANS-ON-CHIPS MARKET, BY PRODUCT & SERVICE,  2022–2029 (USD THOUSAND)
・     TABLE 279          SOUTH KOREA: ORGAN-ON-A-CHIP PRODUCTS MARKET, BY TYPE,  2022–2029 (USD THOUSAND)
・     TABLE 280          SOUTH KOREA: ORGAN-ON-A-CHIP SERVICES MARKET, BY TYPE,  2022–2029 (USD THOUSAND)
・     TABLE 281          SOUTH KOREA: ORGANS-ON-CHIPS MARKET, BY APPLICATION,  2022–2029 (USD THOUSAND)
・     TABLE 282          SOUTH KOREA: ORGANS-ON-CHIPS MARKET, BY PURPOSE,  2022–2029 (USD THOUSAND)
・     TABLE 283          SOUTH KOREA: ORGANS-ON-CHIPS MARKET, BY END USER,  2022–2029 (USD THOUSAND)
12.4.6            REST OF ASIA PACIFIC
・     TABLE 284          REST OF ASIA PACIFIC: ORGANS-ON-CHIPS MARKET, BY ORGAN TYPE,  2022–2029 (USD THOUSAND)
・     TABLE 285          REST OF ASIA PACIFIC: ORGANS-ON-CHIPS MARKET, BY MODEL TYPE,  2022–2029 (USD THOUSAND)
・     TABLE 286          REST OF ASIA PACIFIC: ORGANS-ON-CHIPS MARKET, BY PRODUCT & SERVICE,  2022–2029 (USD THOUSAND)
・     TABLE 287          REST OF ASIA PACIFIC: ORGAN-ON-A-CHIP PRODUCTS MARKET, BY TYPE,  2022–2029 (USD THOUSAND)
・     TABLE 288          REST OF ASIA PACIFIC: ORGAN-ON-A-CHIP SERVICES MARKET, BY TYPE,  2022–2029 (USD THOUSAND)
・     TABLE 289          REST OF ASIA PACIFIC: ORGANS-ON-CHIPS MARKET, BY APPLICATION,  2022–2029 (USD THOUSAND)
・     TABLE 290          REST OF ASIA PACIFIC: ORGANS-ON-CHIPS MARKET, BY PURPOSE,  2022–2029 (USD THOUSAND)
・     TABLE 291          REST OF ASIA PACIFIC: ORGANS-ON-CHIPS MARKET, BY END USER,  2022–2029 (USD THOUSAND)
12.4.7            ASIA PACIFIC: RECESSION IMPACT
12.5          LATIN AMERICA
・     TABLE 292          LATIN AMERICA: ORGANS-ON-CHIPS MARKET, BY COUNTRY,  2022–2029 (USD THOUSAND)
・     TABLE 293          LATIN AMERICA: ORGANS-ON-CHIPS MARKET, BY ORGAN TYPE,  2022–2029 (USD THOUSAND)
・     TABLE 294          LATIN AMERICA: ORGANS-ON-CHIPS MARKET, BY MODEL TYPE,  2022–2029 (USD THOUSAND)
・     TABLE 295          LATIN AMERICA: ORGANS-ON-CHIPS MARKET, BY PRODUCT & SERVICE,  2022–2029 (USD THOUSAND)
・     TABLE 296          LATIN AMERICA: ORGAN-ON-A-CHIP PRODUCTS MARKET, BY TYPE,  2022–2029 (USD THOUSAND)
・     TABLE 297          LATIN AMERICA: ORGAN-ON-A-CHIP SERVICES MARKET, BY TYPE,  2022–2029 (USD THOUSAND)
・     TABLE 298          LATIN AMERICA: ORGANS-ON-CHIPS MARKET, BY APPLICATION,  2022–2029 (USD THOUSAND)
・     TABLE 299          LATIN AMERICA: ORGANS-ON-CHIPS MARKET, BY PURPOSE,  2022–2029 (USD THOUSAND)
・     TABLE 300          LATIN AMERICA: ORGANS-ON-CHIPS MARKET, BY END USER,  2022–2029 (USD THOUSAND)
12.5.1            BRAZIL
12.5.1.1          BAN ON ANIMAL TESTING OF COSMETICS TO SUPPORT MARKET GROWTH
・     TABLE 301          BRAZIL: ORGANS-ON-CHIPS MARKET, BY ORGAN TYPE, 2022–2029 (USD THOUSAND)
・     TABLE 302          BRAZIL: ORGANS-ON-CHIPS MARKET, BY MODEL TYPE,  2022–2029 (USD THOUSAND)
・     TABLE 303          BRAZIL: ORGANS-ON-CHIPS MARKET, BY PRODUCT & SERVICE,  2022–2029 (USD THOUSAND)
・     TABLE 304          BRAZIL: ORGAN-ON-A-CHIP PRODUCTS MARKET, BY TYPE, 2022–2029 (USD THOUSAND)
・     TABLE 305          BRAZIL: ORGAN-ON-A-CHIP SERVICES MARKET, BY TYPE, 2022–2029 (USD THOUSAND)
・     TABLE 306          BRAZIL: ORGANS-ON-CHIPS MARKET, BY APPLICATION, 2022–2029 (USD THOUSAND)
・     TABLE 307          BRAZIL: ORGANS-ON-CHIPS MARKET, BY PURPOSE, 2022–2029 (USD THOUSAND)
・     TABLE 308          BRAZIL: ORGANS-ON-CHIPS MARKET, BY END USER, 2022–2029 (USD THOUSAND)
12.5.2            MEXICO
12.5.2.1          FAVORABLE GOVERNMENT POLICIES TO AID MARKET GROWTH
・     TABLE 309          MEXICO: ORGANS-ON-CHIPS MARKET, BY ORGAN TYPE, 2022–2029 (USD THOUSAND)
・     TABLE 310          MEXICO: ORGANS-ON-CHIPS MARKET, BY MODEL TYPE, 2022–2029 (USD THOUSAND)
・     TABLE 311          MEXICO: ORGANS-ON-CHIPS MARKET, BY PRODUCT & SERVICE,  2022–2029 (USD THOUSAND)
・     TABLE 312          MEXICO: ORGAN-ON-A-CHIP PRODUCTS MARKET, BY TYPE,  2022–2029 (USD THOUSAND)
・     TABLE 313          MEXICO: ORGAN-ON-A-CHIP SERVICES MARKET, BY TYPE, 2022–2029 (USD THOUSAND)
・     TABLE 314          MEXICO: ORGANS-ON-CHIPS MARKET, BY APPLICATION, 2022–2029 (USD THOUSAND)
・     TABLE 315          MEXICO: ORGANS-ON-CHIPS MARKET, BY PURPOSE, 2022–2029 (USD THOUSAND)
・     TABLE 316          MEXICO: ORGANS-ON-CHIPS MARKET, BY END USER, 2022–2029 (USD THOUSAND)
12.5.3            REST OF LATIN AMERICA
・     TABLE 317          REST OF LATIN AMERICA: ORGANS-ON-CHIPS MARKET, BY ORGAN TYPE,  2022–2029 (USD THOUSAND)
・     TABLE 318          REST OF LATIN AMERICA: ORGANS-ON-CHIPS MARKET, BY MODEL TYPE,  2022–2029 (USD THOUSAND)
・     TABLE 319          REST OF LATIN AMERICA: ORGANS-ON-CHIPS MARKET, BY PRODUCT & SERVICE,  2022–2029 (USD THOUSAND)
・     TABLE 320          REST OF LATIN AMERICA: ORGAN-ON-A-CHIP PRODUCTS MARKET, BY TYPE,  2022–2029 (USD THOUSAND)
・     TABLE 321          REST OF LATIN AMERICA: ORGAN-ON-A-CHIP SERVICES MARKET, BY TYPE,  2022–2029 (USD THOUSAND)
・     TABLE 322          REST OF LATIN AMERICA: ORGANS-ON-CHIPS MARKET, BY APPLICATION,  2022–2029 (USD THOUSAND)
・     TABLE 323          REST OF LATIN AMERICA: ORGANS-ON-CHIPS MARKET, BY PURPOSE,  2022–2029 (USD THOUSAND)
・     TABLE 324          REST OF LATIN AMERICA: ORGANS-ON-CHIPS MARKET, BY END USER,  2022–2029 (USD THOUSAND)
12.5.4            LATIN AMERICA: RECESSION IMPACT
12.6          MIDDLE EAST & AFRICA
12.6.1            GROWING PHARMACEUTICAL INDUSTRY TO SUPPORT MARKET GROWTH
・     TABLE 325          MIDDLE EAST & AFRICA: ORGANS-ON-CHIPS MARKET, BY ORGAN TYPE,  2022–2029 (USD THOUSAND)
・     TABLE 326          MIDDLE EAST & AFRICA: ORGANS-ON-CHIPS MARKET, BY MODEL TYPE,  2022–2029 (USD THOUSAND)
・     TABLE 327          MIDDLE EAST & AFRICA: ORGANS-ON-CHIPS MARKET, BY PRODUCT & SERVICE,  2022–2029 (USD THOUSAND)
・     TABLE 328          MIDDLE EAST & AFRICA: ORGAN-ON-A-CHIP PRODUCTS MARKET, BY TYPE,  2022–2029 (USD THOUSAND)
・     TABLE 329          MIDDLE EAST & AFRICA: ORGAN-ON-A-CHIP SERVICES MARKET, BY TYPE,  2022–2029 (USD THOUSAND)
・     TABLE 330          MIDDLE EAST & AFRICA: ORGANS-ON-CHIPS MARKET, BY APPLICATION,  2022–2029 (USD THOUSAND)
・     TABLE 331          MIDDLE EAST & AFRICA: ORGANS-ON-CHIPS MARKET, BY PURPOSE,  2022–2029 (USD THOUSAND)
・     TABLE 332          MIDDLE EAST & AFRICA: ORGANS-ON-CHIPS MARKET, BY END USER,  2022–2029 (USD THOUSAND)
12.6.2            MIDDLE EAST & AFRICA: RECESSION IMPACT

13   COMPETITIVE LANDSCAPE

13.1          INTRODUCTION
13.2          KEY STRATEGIES/RIGHT TO WIN
・     FIGURE 34          MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN ORGANS-ON-CHIPS MARKET
13.3          REVENUE SHARE ANALYSIS
・     FIGURE 35          REVENUE SHARE ANALYSIS, 2021–2023 (USD THOUSAND)
13.4          MARKET SHARE ANALYSIS
・     FIGURE 36          MARKET SHARE ANALYSIS, 2023   271
・     TABLE 333          DEGREE OF COMPETITION: ORGANS-ON-CHIPS MARKET
13.5          COMPANY EVALUATION MATRIX: KEY PLAYERS
13.5.1            STARS
13.5.2            EMERGING LEADERS
13.5.3            PERVASIVE PLAYERS
13.5.4            PARTICIPANTS
・     FIGURE 37          ORGANS-ON-CHIPS MARKET: COMPANY EVALUATION MATRIX  (KEY PLAYERS), 2023
13.5.5            COMPANY FOOTPRINT
・     TABLE 334          PRODUCT & SERVICE FOOTPRINT
・     TABLE 335          REGIONAL FOOTPRINT
13.6          COMPANY EVALUATION MATRIX: START-UPS/SMES
13.6.1            PROGRESSIVE COMPANIES
13.6.2            RESPONSIVE COMPANIES
13.6.3            DYNAMIC COMPANIES
13.6.4            STARTING BLOCKS
・     FIGURE 38          ORGANS-ON-CHIPS MARKET: COMPANY EVALUATION MATRIX (START-UPS/SMES), 2023
13.6.5            COMPETITIVE BENCHMARKING
・     TABLE 336          DETAILED LIST OF KEY START-UPS/SMES IN ORGANS-ON-CHIPS MARKET
・     TABLE 337          COMPETITIVE BENCHMARKING OF START-UPS/SMES IN ORGANS-ON-CHIPS MARKET
13.7          COMPETITIVE SCENARIO
13.7.1            PRODUCT/SERVICE LAUNCHES
・     TABLE 338          ORGANS-ON-CHIPS MARKET: PRODUCT/ SERVICE LAUNCHES, 2021–2024
13.7.2            DEALS
・     TABLE 339          ORGANS-ON-CHIPS MARKET: DEALS, 2021–2024
13.7.3            OTHER KEY DEVELOPMENTS
・     TABLE 340          ORGANS-ON-CHIPS MARKET: OTHER DEVELOPMENTS, 2021–2024

14   COMPANY PROFILES

14.1          KEY PLAYERS   281
(BUSINESS OVERVIEW, PRODUCTS OFFERED, RECENT DEVELOPMENTS, AND MNM VIEW (KEY STRENGTHS/RIGHT TO WIN, STRATEGIC CHOICES MADE, AND WEAKNESSES AND COMPETITIVE THREATS))*
14.1.1            EMULATE, INC.
・     TABLE 341          EMULATE, INC.: COMPANY OVERVIEW
・     TABLE 342          EMULATE, INC.: PRODUCT/SERVICE LAUNCHES, 2021–2024
・     TABLE 343          EMULATE, INC.: OTHER DEVELOPMENTS, 2021–2024
14.1.2            MIMETAS B.V.
・     TABLE 344          MIMETAS B.V.: COMPANY OVERVIEW
・     TABLE 345          MIMETAS B.V.: DEALS, 2021–2024
・     TABLE 346          MIMETAS B.V.: OTHER DEVELOPMENTS, 2021–2024
14.1.3            TISSUSE GMBH
・     TABLE 347          TISSUSE GMBH: COMPANY OVERVIEW
・     TABLE 348          TISSUSE GMBH: DEALS, 2021–2024
・     TABLE 349          TISSUSE GMBH: OTHER DEVELOPMENTS, 2021–2024
14.1.4            CN BIO INNOVATIONS LTD.
・     TABLE 350          CN BIO INNOVATIONS LTD.: COMPANY OVERVIEW
・     TABLE 351          CN BIO INNOVATIONS LTD.: PRODUCT/SERVICE LAUNCHES, 2021–2024
・     TABLE 352          CN BIO INNOVATIONS LTD.: DEALS, 2021–2024
14.1.5            INSPHERO
・     TABLE 353          INSPHERO: COMPANY OVERVIEW
・     TABLE 354          INSPHERO: DEALS, 2021–2024
・     TABLE 355          INSPHERO: OTHER DEVELOPMENTS, 2021–2024
14.1.6            ALVEOLIX AG
・     TABLE 356          ALVEOLIX AG: COMPANY OVERVIEW
・     TABLE 357          ALVEOLIX AG: PRODUCT LAUNCHES, 2021–2024
・     TABLE 358          ALVEOLIX AG: DEALS, 2021–2024
14.1.7            FLUIGENT
・     TABLE 359          FLUIGENT: COMPANY OVERVIEW
・     TABLE 360          FLUIGENT: PRODUCT/SERVICE LAUNCHES, 2021–2024
14.1.8            NORTIS, INC.
・     TABLE 361          NORTIS, INC.: COMPANY OVERVIEW
14.1.9            HESPEROS, INC.
・     TABLE 362          HESPEROS, INC.: COMPANY OVERVIEW
・     TABLE 363          HESPEROS, INC.: OTHER DEVELOPMENTS, 2021–2024
14.1.10         AXOSIM
・     TABLE 364          AXOSIM: COMPANY OVERVIEW
・     TABLE 365          AXOSIM: PRODUCT LAUNCHES, 2021–2024
・     TABLE 366          AXOSIM: DEALS, 2021–2024
14.1.11         BEONCHIP
・     TABLE 367          BEONCHIP: COMPANY OVERVIEW
14.1.12         ALTIS BIOSYSTEMS
・     TABLE 368          ALTIS BIOSYSTEMS: COMPANY OVERVIEW
・     TABLE 369          ALTIS BIOSYSTEMS: PRODUCT/SERVICE LAUNCHES, 2021–2024
・     TABLE 370          ALTIS BIOSYSTEMS: DEALS, 2021–2024
14.1.13         SYNVIVO, INC.
・     TABLE 371          SYNVIVO, INC.: COMPANY OVERVIEW
14.1.14         OBATALA SCIENCES
・     TABLE 372          OBATALA SCIENCES: COMPANY OVERVIEW
14.1.15         DYNAMIC42 GMBH
・     TABLE 373          DYNAMIC42 GMBH: COMPANY OVERVIEW
・     TABLE 374          DYNAMIC42 GMBH: PRODUCT LAUNCHES, 2021–2024
・     TABLE 375          DYNAMIC42 GMBH: DEALS, 2021–2024
・     TABLE 376          DYNAMIC42 GMBH: OTHER DEVELOPMENTS, 2021–2024
14.1.16         LENA BIOSCIENCES
・     TABLE 377          LENA BIOSCIENCES: COMPANY OVERVIEW
・     TABLE 378          LENA BIOSCIENCES: OTHER DEVELOPMENTS, 2021–2024
14.1.17         AIM BIOTECH PTE. LTD.
・     TABLE 379          AIM BIOTECH PTE. LTD.: COMPANY OVERVIEW
・     TABLE 380          AIM BIOTECH PTE. LTD.: PRODUCT/SERVICES LAUNCHES, 2021–2024
・     TABLE 381          AIM BIOTECH PTE. LTD.: DEALS, 2021–2024
14.1.18         REACT4LIFE
・     TABLE 382          REACT4LIFE: COMPANY OVERVIEW
14.1.19         INITIO CELL
・     TABLE 383          INITIO CELL: COMPANY OVERVIEW
14.1.20         NETRI SAS
・     TABLE 384          NETRI SAS: COMPANY OVERVIEW
・     TABLE 385          NETRI SAS: PRODUCT LAUNCHES, 2021–2024
・     TABLE 386          NETRI SAS: DEALS, 2021–2024   333
・     TABLE 387          NETRI SAS: OTHER DEVELOPMENTS, 2021–2024
14.1.21         REVIVOCELL
・     TABLE 388          REVIVOCELL: COMPANY OVERVIEW
14.1.22         BI/OND
・     TABLE 389          BI/OND: COMPANY OVERVIEW
・     TABLE 390          BI/OND: OTHER DEVELOPMENTS, 2021–2024
14.1.23         BIOMIMX S.R.L.
・     TABLE 391          BIOMIMX S.R.L.: COMPANY OVERVIEW
14.1.24         CHERRY BIOTECH
・     TABLE 392          CHERRY BIOTECH: COMPANY OVERVIEW
14.1.25         ELVESYS
・     TABLE 393          ELVESYS: COMPANY OVERVIEW
14.1.26         JAVELIN BIOTECH
・     TABLE 394          JAVELIN BIOTECH: COMPANY OVERVIEW
・     TABLE 395          JAVELIN BIOTECH: DEALS, 2021–2024
14.1.27         KIRKSTALL LTD.
・     TABLE 396          KIRKSTALL LTD.: COMPANY OVERVIEW
*DETAILS ON BUSINESS OVERVIEW, PRODUCTS OFFERED, RECENT DEVELOPMENTS, AND MNM VIEW (KEY STRENGTHS/RIGHT TO WIN, STRATEGIC CHOICES MADE, AND WEAKNESSES AND COMPETITIVE THREATS) MIGHT NOT BE CAPTURED IN CASE OF UNLISTED COMPANIES.

15             APPENDIX

△ 一番上に戻る